Advanced search
Publication Cover
Acta Oncologica Volume 51, 2012 - Issue 3
Journal homepage
1,305
Views
19
CrossRef citations to date
0
Altmetric
Letter

Insulin glargine use and short-term incidence of breast cancer — a four-year population-based observation

Rickard LjungNational Board of Health and Welfare, Stockholm, Sweden;Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;Equity and Health Policy, Department of Public Health Sciences, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
,
Mats TalbäckNational Board of Health and Welfare, Stockholm, Sweden
,
Bengt HaglundNational Board of Health and Welfare, Stockholm, Sweden
,
Junmei Miao JonassonDivision of Clinical Cancer Epidemiology, Department of Oncology, The Sahlgrenska Academy, Onkologiskt Centrum, Gothenburg, Sweden;Division of Clinical Cancer Epidemiology, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;National Diabetes Register, Register Center, Västra Götaland Region, Sweden
,
Soffia GudbjörnsdòttirDiabetes Centre, Sahlgrenska University Hospital, Gothenburg, Sweden;Nordic School of Public Health, Gothenburg, Sweden;National Diabetes Register, Register Center, Västra Götaland Region, Sweden
&
Gunnar SteineckDivision of Clinical Cancer Epidemiology, Department of Oncology, The Sahlgrenska Academy, Onkologiskt Centrum, Gothenburg, Sweden
Pages 400-402 | Received 11 Jul 2011, Accepted 12 Sep 2011, Published online: 12 Apr 2012

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Joshua J Joseph & Thomas W Donner. (2015) Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes. Vascular Health and Risk Management 11, pages 107-116.
Read now

Articles from other publishers (18)

Jiying Qi, Ping He, Huayan Yao, Wen Sun, Ping Lu, Zizheng Zhang, Bin Cui & Guang Ning. (2023) Insulin glargine use and cancer risk among patients with type 2 diabetes mellitus: a real-world study in Shanghai, China. International Journal of Diabetes in Developing Countries.
Crossref
Ya Wang, Xinling Zeng, Jie Tan, Yi Xu & Cunjian Yi. (2022) Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links. Medicine 101:34, pages e30299.
Crossref
Saira Sattar, Muhammad Faisal Nisar & Onyeka Kingsley Nwosu. 2021. Dietary Phytochemicals. Dietary Phytochemicals 81 93 .
Hulda Hrund Bjornsdottir, Araz Rawshani, Aidin Rawshani, Stefan Franzén, Ann-Marie Svensson, Naveed Sattar & Soffia Gudbjörnsdottir. (2020) A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time. Scientific Reports 10:1.
Crossref
Han-Lin Lu, Yuan-Chih Su, Mei-Chen Lin, Mao-Feng Sun & Sheng-Teng Huang. (2020) Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study. Complementary Therapies in Medicine 49, pages 102332.
Crossref
Morten Hasselstrøm Jensen, Ole Hejlesen & Peter Vestergaard. (2019) Risk of major cardiovascular events, severe hypoglycaemia, and all‐cause mortality for users of insulin degludec versus insulin glargine U100—A Danish cohort study. Diabetes/Metabolism Research and Reviews 36:1.
Crossref
Yi-Chun Liu, Phung-Anh Nguyen, Ayesha Humayun, Shuo-Chen Chien, Hsuan-Chia Yang, Rahma Novita Asdary, Shabbir Syed-Abdul, Min-Huei Hsu, Max Moldovan, Yun Yen, Yu-Chuan (Jack) Li, Wen-Shan Jian & Usman Iqbal. (2019) Does long-term use of antidiabetic drugs changes cancer risk?. Medicine 98:40, pages e17461.
Crossref
Emily Jane Gallagher & Derek LeRoith. (2015) Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Physiological Reviews 95:3, pages 727-748.
Crossref
Kyong Hye Joung, Jae-Wook Jeong & Bon Jeong Ku. (2015) The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms. BioMed Research International 2015, pages 1-12.
Crossref
Hans-Georg Joost. (2014) Diabetes and cancer: Epidemiology and potential mechanisms. Diabetes and Vascular Disease Research 11:6, pages 390-394.
Crossref
Laurel A. Habel, Kim N. Danforth, Charles P. Quesenberry, Angela Capra, Stephen K. Van Den Eeden, Noel S. Weiss & Assiamira Ferrara. (2013) Cohort Study of Insulin Glargine and Risk of Breast, Prostate, and Colorectal Cancer Among Patients With Diabetes. Diabetes Care 36:12, pages 3953-3960.
Crossref
Tiange Wang, Guang Ning & Zachary Bloomgarden. (2013) Diabetes and cancer relationships (糖尿病与肿瘤的关联性). Journal of Diabetes 5:4, pages 378-390.
Crossref
Til Stürmer, M. Alison Marquis, Haibo Zhou, James B. Meigs, Soo Lim, Lawrence Blonde, Eileen MacDonald, Ray Wang, Lisa M. LaVange, Virginia Pate & John B. Buse. (2013) Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin. Diabetes Care 36:11, pages 3517-3525.
Crossref
Emily J. Gallagher & Derek LeRoith. (2013) Diabetes, antihyperglycemic medications and cancer risk. Current Opinion in Endocrinology, Diabetes & Obesity 20:5, pages 485-494.
Crossref
Yehuda Handelsman, Derek LeRoith, Zachary T. Bloomgarden, Samuel Dagogo-Jack, Daniel Einhorn, Alan J. Garber, George Grunberger, R. Mack Harrell, Robert F. Gagel, Harold E. Lebovitz, Janet B. McGill & Charles H. Hennekens. (2013) Diabetes and Cancer—An AACE/ACE Consensus Statement. Endocrine Practice 19:4, pages 675-693.
Crossref
Etan Orgel & Steven D. Mittelman. (2012) The Links Between Insulin Resistance, Diabetes, and Cancer. Current Diabetes Reports 13:2, pages 213-222.
Crossref
Emily J. Gallagher & Derek LeRoith. (2013) Diabetes, Antihyperglycemic Medications and Cancer Risk: Smoke or Fire?. Endocrine Practice 1:-1, pages 1-28.
Crossref
Rosalyn D. Ferguson, Emily J. Gallagher, Eyal J. Scheinman, Rawan Damouni & Derek LeRoith. 2013. Hormones and Breast Cancer. Hormones and Breast Cancer 51 98 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.